See also this year's filing and all EDGAR filings for this company.
PDF Report 0001177648_2023_ENANTA_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001177648, ENANTA PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 311,713,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,173,000 |
| 3 | remainder_Assets | 57,524,000 |
| 4 | LiabilitiesCurrent | 29,827,000 |
| 5 | LiabilitiesNoncurrent | 22,826,000 |
| 6 | remainder_Liabilities | 1,423,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 45,482,000 |
| 9 | ResearchAndDevelopmentExpense | 164,522,000 |
| 10 | remainder_Expenses | -433,000 |
| 11 | remainder_Revenues | 86,160,000 |
| 12 | remainder_NetIncome | 1,656,000 |
| 13 | remainder_ComprehensiveNetIncome | -3,342,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 375,410,000 |
| 1 | Liabilities | 54,076,000 |
| 2 | Expenses | 209,571,000 |
| 3 | Revenues | 86,160,000 |
| 4 | StockholdersEquity | 321,334,000 |
| 5 | NetIncome | -121,755,000 |
| 6 | ComprehensiveNetIncome | -123,426,000 |
| 7 | BaseVar | 365,107,500 |
| 8 | EconomicCapitalRatio | 2.00 |
Edgar->Model Mapping
Feature Distribution
Change over Time
